AydınCDemirkıranAOrtaH.C-reactive protein–albumin–lymphocyte (CALLY) index and length of hospital stay in patients with heart failure. Angiology. 2026;77:779-780.
2.
CandemirMKızıltunçEYamakBA.Association between the C-reactive protein-albumin-lymphocyte (CALLY) index and length of hospital stay in patients with heart failure. Angiology. 2026;77:772-778
3.
ZhangXSuY.Low prognostic nutritional index predicts adverse outcomes in patients with heart failure: a systematic review and meta-analysis. Angiology. 2024;75(4):305-313.
4.
VakhshooriMNematiSSabouhiS, et al. Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23(1):555.
5.
ZhengHYinZLuoXZhouYZhangFGuoZ.Associations between systemic immunity-inflammation index and heart failure: evidence from the NHANES 1999-2018. Int J Cardiol. 2024;395:131400.
6.
ZhuDWangCZhouY, et al. The associations of two novel inflammation biomarkers, SIRI and SII, with mortality risk in patients with chronic heart failure. J Inflamm Res. 2024;17:1255-1264.
7.
ValenteMAVoorsAADammanK, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35(19):1284-1293.
8.
GreeneSJButlerJAlbertNM, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry. J Am Coll Cardiol. 2018;72(4):351-366.
